BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11069054)

  • 1. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias.
    Poggi A; Pellegatta F; Leone BE; Moretta L; Zocchi MR
    Eur J Immunol; 2000 Oct; 30(10):2751-8. PubMed ID: 11069054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
    Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
    J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
    Robbins MA; Maksumova L; Pocock E; Chantler JK
    Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
    Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
    Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ajoene, an experimental anti-leukemic drug: mechanism of cell death.
    Dirsch VM; Antlsperger DS; Hentze H; Vollmar AM
    Leukemia; 2002 Jan; 16(1):74-83. PubMed ID: 11840266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes.
    Kühn K; Lotz M
    Arthritis Rheum; 2001 Jul; 44(7):1644-53. PubMed ID: 11465715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p38 kinase reveals a TNF-alpha-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line.
    Varghese J; Chattopadhaya S; Sarin A
    J Immunol; 2001 Jun; 166(11):6570-7. PubMed ID: 11359809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells.
    Panet H; Barzilai A; Daily D; Melamed E; Offen D
    J Neurochem; 2001 Apr; 77(2):391-8. PubMed ID: 11299301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.
    Cahir-McFarland ED; Davidson DM; Schauer SL; Duong J; Kieff E
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6055-60. PubMed ID: 10811897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector.
    Busuttil V; Bottero V; Frelin C; Imbert V; Ricci JE; Auberger P; Peyron JF
    Oncogene; 2002 May; 21(20):3213-24. PubMed ID: 12082637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
    Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
    Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF induces caspase-dependent inflammation in renal endothelial cells through a Rho- and myosin light chain kinase-dependent mechanism.
    Wu X; Guo R; Chen P; Wang Q; Cunningham PN
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F316-26. PubMed ID: 19420112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.